×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

3393 Total Publications

Semiautomated Assessment of the Anterior Cingulate Cortex in Alzheimer's Disease
Jung, F., Kazemifar, S., Bartha, R. and Rajakumar, N.
2019; Journal J Neuroimaging;
EARLY DIAGNOSIS OF NEUROLOGICAL DISEASE USING PEAK DEGENERATION AGES OF MULTIPLE BIOMARKERS
Gao, F, Wang, Y and Zeng, D
2019; Journal Ann Appl Stat; vol. 13; no. 2; pp. 1295-1318;
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
Mattsson, N, Cullen, N., Andreasson, U., Zetterberg, H., Blennow, K.
2019; Journal JAMA Neurology; vol. 76; no. 7; pp. 791-799;
Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?
McLimans, KE, Clark, BE, Plagman, A, Pappas, C, Klinedinst, B, Anatharam, V, Kanthasamy, A, Willette, AA and Alzheimers Dis Neuroimaging, I
2019; Journal Antioxidants & Redox Signaling; vol. 31; no. 8; pp. 572-578;
Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
Grill, JDN, M. M.: Gillen, D. L.
2019; Journal Alzheimer Dis Assoc Disord;
The effect of ApoE epsilon4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study
Paranjpe, MDC, X.: Liu, M.: Paranjpe, I.: Leal, J. P.: Wang, R.: Pomper, M. G.: Wong, D. F.: Benzinger, T. L. S.: Zhou, Y.
2019; Journal Neuroimage Clin; vol. 22; pp. 101795;
Key inflammatory pathway activations in the MCI stage of Alzheimer's disease
Pillai, JAM, S.: Bena, J.: Bekris, L. M.: Rao, S. M.: Chance, M.: Lamb, B. T.: Leverenz, J. B.
2019; Journal Ann Clin Transl Neurol; vol. 6; no. 7; pp. 1248-1262;
Cholecystokinin and Alzheimer’s Disease: A Biomarker of Metabolic Function, Neural Integrity, and Cognitive Performance
Plagman, Alexandra, Hoscheidt, Siobhan, McLimans, Kelsey E, Klinedinst, Brandon, Pappas, Colleen, Anantharam, Vellareddy, Kanthasamy, Anumantha, Willette, Auriel A and Initiative, Alzheimer’s Disease Neuroimaging
2019; Journal Neurobiology of Aging;
Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images
Gupta, Y, Lee, KH, Choi, KY, Lee, JJ, Kim, BC and Kwon, GR
2019; Journal PLoS One; vol. 14; no. 10; pp. e0222446;
Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration
Tan, CH, Bonham, LW, Fan, CC, Mormino, EC, Sugrue, LP, Broce, IJ, Hess, CP, Yokoyama, JS, Rabinovici, GD, Miller, BL, Yaffe, K, Schellenberg, GD, Kauppi, K, Holland, D, McEvoy, LK, Kukull, WA, Tosun, D, Weiner, MW, Sperling, RA, Bennett, DA, Hyman, BT, Andreassen, OA, Dale, AM, Desikan, RS and Alzheimers Dis, N
2019; Journal Brain; vol. 142; pp. 460-470;